Procter & Gamble to pick up Merck's consumer healthcare unit

April 19, 2018
Merck had been seeking options for its consumer healthcare business for months

German pharmaceutical and chemicals group Merck said Thursday it had agreed to sell its consumer health business to American giant Procter & Gamble and would use the proceeds mostly to pay off debt.

As part of the 3.4-billion euro ($4.2 billion) cash deal, some 3,300 staff will move from Merck to Procter & Gamble, it said in a statement.

Merck had announced in September that it was looking at options for the consumer health business, including a possible sale.

On Thursday, Merck said it would use the net proceeds from the spinoff "primarily to accelerate deleveraging", but also to give its key businesses—, and performance materials—extra financial clout.

Procter & Gamble's CEO David Taylor, meanwhile, said his company liked "the steady, broad-based growth" of the over-the-counter healthcare market.

Merck said its consumer healthcare , which comprises more than 900 products sold in 44 countries, had outperformed the market's overall growth in the past three years.

The deal is to be completed by the end of the year.

Germany's Merck, founded in 1668, is the world's oldest chemical and pharmaceutical company. It employs 53,000 staff across the world and had sales last year of 25.3 billion euros.

Explore further: Merck completes sale of consumer unit to Bayer

Related Stories

Merck completes sale of consumer unit to Bayer

October 1, 2014
Drugmaker Merck said Wednesday that it completed the sale of its consumer care business, which makes products including Claritin allergy medication and Coppertone sun-care line, to German health care company Bayer for $14.2 ...

German drug maker Merck ups forecast for 2013

November 14, 2013
German chemicals and pharmaceuticals giant Merck KGaA said Thursday it is raising its full-year operating profit forecast thanks to improving sales and positive cost-cutting effects.

Germany's Merck suffers setback with cancer drug

December 19, 2012
German pharmaceutical company Merck KgaA says a late stage trial of a new lung cancer drug has failed to meet expectations.

Higher prices for MS drug help drug firm Merck

May 14, 2013
(AP)—Higher prices for its multiple sclerosis drug Rebif helped German pharmaceutical and high-tech materials company Merck KGaA post a 54 percent rise in first-quarter profit.

Recommended for you

Yes, you can put too much chlorine in a pool

June 2, 2018
(HealthDay)—Before you take a dip in the pool this summer, be sure there's not too much chlorine in the water.

Best of Last Year—The top Medical Xpress articles of 2017

December 20, 2017
It was a good year for medical research as a team at the German center for Neurodegenerative Diseases, Magdeburg, found that dancing can reverse the signs of aging in the brain. Any exercise helps, the team found, but dancing ...

Pickled in 'cognac', Chopin's heart gives up its secrets

November 26, 2017
The heart of Frederic Chopin, among the world's most cherished musical virtuosos, may finally have given up the cause of his untimely death.

Sugar industry withheld evidence of sucrose's health effects nearly 50 years ago

November 21, 2017
A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the ...

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.